Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA128170
Max Phase: Preclinical
Molecular Formula: C22H30N4OS
Molecular Weight: 398.58
Molecule Type: Small molecule
Associated Items:
ID: ALA128170
Max Phase: Preclinical
Molecular Formula: C22H30N4OS
Molecular Weight: 398.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)SCN(CCCCN2CCN(c3ccc4ccccc4n3)CC2)C1=O
Standard InChI: InChI=1S/C22H30N4OS/c1-22(2)21(27)26(17-28-22)12-6-5-11-24-13-15-25(16-14-24)20-10-9-18-7-3-4-8-19(18)23-20/h3-4,7-10H,5-6,11-17H2,1-2H3
Standard InChI Key: LQKJNLJPXWCMKZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 398.58 | Molecular Weight (Monoisotopic): 398.2140 | AlogP: 3.45 | #Rotatable Bonds: 6 |
Polar Surface Area: 39.68 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.99 | CX LogP: 3.59 | CX LogD: 2.90 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.70 | Np Likeness Score: -1.30 |
1. Hrib NJ, Jurcak JG, Bregna DE, Burgher KL, Hartman HB, Kafka S, Kerman LL, Kongsamut S, Roehr JE, Szewczak MR, Woods-Kettelberger AT, Corbett R.. (1996) Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate., 39 (20): [PMID:8831770] [10.1021/jm960268u] |
Source(1):